Hormel Foods 8-K 2014
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
Pursuant to Section 13 or 15 (d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) August 11, 2014
HORMEL FOODS CORPORATION
(Exact name of registrant as specified in its charter)
1 Hormel Place
Austin, MN 55912
(Address of Principal Executive Office)
Registrants telephone number, including area code: (507) 437-5611
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Section 2 FINANCIAL INFORMATION
Item 2.01 Completion of Acquisition or Disposition of Assets
On August 11, 2014, Hormel Foods Corporation (the Company) completed the previously announced acquisition of CytoSport Holdings, Inc., maker of Muscle Milk® products.
The purchase price is approximately $450 million.
The agreement provides for a potential additional payment of up to $20 million subject to meeting specific financial performance criteria over the next two years.
Section 7 REGULATION FD
Item 7.01 Regulation FD Disclosure
On August 12, 2014, the Company issued a press release announcing the closing of the acquisition of CytoSport Holdings, Inc., maker of Muscle Milk® products. A copy of the press release is furnished as Exhibit 99 to this Form 8-K and is incorporated herein by reference.
Section 9 FINANCIAL STATEMENTS AND EXHIBITS
Item 9.01 Financial Statements and Exhibits
(d) Exhibits furnished pursuant to Item 7.01
99 Press release issued August 12, 2014
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.